MicroRNA Genetic Variation: From Population Analysis to Functional Implications of Three Allele Variants Associated with Cancer

Human Mutation

Volumn 37, Issue 10, 2016, Pages 1060-1073

  Torruella Loran, Ignasi ^a   Laayouni, Hafid ^a,b   Dobon, Begoña ^a   Gallego, Alicia ^a   Balcells, Ingrid ^a   Garcia Ramallo, Eva ^a   Espinosa Parrilla, Yolanda ^a,c  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSIDAD DE MAGALLANES   (Chile)

Author keywords

cancer; functional allele variant; genetic association; microRNA

Indexed keywords

ATP BINDING CASSETTE TRANSPORTER 2; C1Q TUMOR NECROSIS FACTOR RELATED PROTEIN 3; CADHERIN 1; CELL ADHESION MOLECULE; CELL ADHESION MOLECULE L1 LIKE PROTEIN; CLH PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; HSA MIR 146A 3P; HSA MIR 196A 3P; HSA MIR 449C; HSA MIR 499A 3P; HSA MIR 499B 5P; INTERLEUKIN 24; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS4; KIT PROTEIN; MICRORNA; MICRORNA499A; PROTEIN; PROTEIN P53; RIBONUCLEOTIDE REDUCTASE M2 B; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTOME; UNCLASSIFIED DRUG; UVOMORULIN;

AFRICAN; ALGORITHM; ALLELE; ARTICLE; ASIAN; CARCINOGENESIS; CONTROLLED STUDY; DNA FLANKING REGION; EUROPEAN; GENE FREQUENCY; GENETIC VARIATION; GENOME; HUMAN; HUMAN CELL; LOCAL ADAPTATION; LUCIFERASE ASSAY; MALIGNANT NEOPLASTIC DISEASE; PREDICTION; PRIORITY JOURNAL; PURIFYING SELECTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84987719155     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.23045     Document Type: Article

References (72)

1. Akey JM, Zhang G, Zhang K, Jin L, Shriver MD. 2002. Interrogating a high-density SNP map for signatures of natural selection. Genome Res 12:1805–1814.
2. Altshuler D, Lander E, Ambrogio L. 2010. A map of human genome variation from population scale sequencing. Nature 476:1061–1073.
3. Balcells I, Cirera S, Busk PK. 2011. Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers. BMC Biotechnol 11:70.
4. Barreiro LB, Laval G, Quach H, Patin E, Quintana-Murci L. 2008. Natural selection has driven population differentiation in modern humans. Nat Genet 40:340–345.
5. Bartel DP. 2014. MicroRNAs: target recognition and regulatory functions. Cell 136:215–233.
6. Bray F, McCarron P, Parkin DM. 2004. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6:229–239.
7. Busk PK. 2014. A tool for design of primers for microRNA-specific quantitative RT-qPCR. BMC Bioinformatics 15:29.
8. Carbonell J, Alloza E, Arce P, Borrego S, Santoyo J, Ruiz-Ferrer M, Medina I, Jimenez-Almazan J, Mendez-Vidal C, Gonzalez-del Pozo M, Vela A, Bhattacharya SS, et al. 2012. A map of human microRNA variation uncovers unexpectedly high levels of variability. Genome Med 4:62.
9. Chen C, Yang S, Chaugai S, Wang Y, Wang D. 2014. Meta-analysis of Hsa-mir-499 polymorphism (rs3746444) for cancer risk: evidence from 31 case-control studies. BMC Med Genet 15:126.
10. Chen C, Zhang Y, Zhang L, Weakley SM, Yao Q. 2011. MicroRNA-196: critical roles and clinical applications in development and cancer. J Cell Mol Med 15:14–23.
11. Danecek P, Auton A, Abecasis G, Albers CA, Banks E, DePristo MA, Handsaker RE, Lunter G, Marth GT, Sherry ST, McVean G, Durbin R. 2011. The variant call format and VCFtools. Bioinformatics 27:2156–2158.
12. Di Leva G, Garofalo M, Croce CM. 2014. MicroRNAs in cancer. Annu Rev Pathol Mech Dis 9:287–314.
13. Domanska UM, Kruizinga RC, Nagengast WB, Timmer-Bosscha H, Huls G, de Vries EGE, Walenkamp AME. 2013. A review on CXCR4/CXCL12 axis in oncology: no place to hide. Eur J Cancer 49:219–230.
14. Duan R, Pak CH, Jin P. 2007. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 16:1124–1131.
15. Esquela-Kerscher A, Slack FJ. 2006. Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6:259–269.
16. Fan Y, Fan J, Huang L, Ye M, Huang Z, Wang Y, Li Q, Huang J. 2015. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma. 8:4132–4137.
17. Foulkes WD, Priest JR, Duchaine TF. 2014. DICER1: mutations, microRNAs and mechanisms. Nat Rev Cancer 14:662–672.
18. Friedman RC, Farh KKH, Burge CB, Bartel DP. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92–105.
19. Fu B, Song P, Lu M, Wang B, Zhao Q. 2014. The association between miR-146a gene rs2910164 polymorphism and gastric cancer risk: a meta-analysis. Biomed Pharmacother 68:923–928.
20. Gallego A, Melé M, Balcells I, García-Ramallo E, Torruella-Loran I, Fernández-Bellon H, Abelló T, Kondova I, Bontrop R, Hvilsom C, Navarro A, Marquès-Bonet T, et al. 2016. Functional implications of human-specific changes in great ape microRNAs. PLoS One 11:e0154194.
21. Gara SK, Jia L, Merino MJ, Agarwal SK, Zhang L, Cam M, Patel D, Kebebew E. 2015. Germline HABP2 mutation causing familial nonmedullary thyroid cancer. N Engl J Med 373:448–455.
22. Gardner M, Bertranpetit J, Comas D. 2008. Worldwide genetic variation in dopamine and serotonin pathway genes: implications for association studies. Am J Med Genet B Neuropsychiatr Genet 147B:1070–1075.
23. Ghanbari M, de Vries PS, de Looper H, Peters MJ, Schurmann C, Yaghootkar H, Dörr M, Frayling TM, Uitterlinden AG, Hofman A, van Meurs JBJ, Erkeland SJ, et al. 2014. A genetic variant in the seed region of miR-4513 shows pleiotropic effects on lipid and glucose homeostasis, blood pressure, and coronary artery disease. Hum Mutat 35:1524–1531.
24. Ghanbari M, Darweesh SKL, de Looper HWJ, van Luijn MM, Hofman A, Ikram MA, Franco OH, Erkeland SJ, Dehghan A. 2016. Genetic variants in microRNAs and their binding sites are associated with the risk of Parkinson disease. Hum Mutat, 37:292–300.
25. Grossman SR, Shylakhter I, Karlsson EK, Byrne EH, Morales S, Frieden G, Hostetter E, Angelino E, Garber M, Zuk O, Lander ES, Schaffner SF, et al. 2010. A composite of multiple signals distinguishes causal variants in regions of positive selection. Science 327:883–886.
26. Guidi M, Muiños-Gimeno M, Kagerbauer B, Martí E, Estivill X, Espinosa-Parrilla Y. 2010. Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells. BMC Mol Biol 11:95.
27. Hecker M, Fitzner B, Blaschke J, Blaschke P, Zettl UK. 2015. Susceptibility variants in the CD58 gene locus point to a role of microRNA-548ac in the pathogenesis of multiple sclerosis. Mutat Res Rev Mutat Res 763:161–167.
28. Hill CG, Jabbari N, Matyunina L V, McDonald JF. 2014. Functional and evolutionary significance of human microRNA seed region mutations. PLoS One 9:e115241.
29. Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, Zhang Y, Paranjape T, Zhu Y. 2009. microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res 69:5970–5977.
30. Hou W, Tian Q, Zheng J, Bonkovsky HL. 2010. MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins. Hepatology 51:1494–1504.
31. Hrdlickova B, de Almeida RC, Borek Z, Withoff S. 2014. Genetic variation in the non-coding genome: involvement of micro-RNAs and long non-coding RNAs in disease. Biochim Biophys Acta 1842:1910–1922.
32. Hsieh J-Y, Huang T-S, Cheng S-M, Lin W-S, Tsai T-N, Lee OK, Wang H-W. 2013. miR-146a-5p circuitry uncouples cell proliferation and migration, but not differentiation, in human mesenchymal stem cells. Nucleic Acids Res 41:9753–9763.
33. Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, Chan WL, Tsai WT, Chen GZ, Lee CJ, Chiu CM, Chien CH, Wu MC, et al. 2011. MiRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 39:163–169.
34. Hui ABY, Shi W, Boutros PC, Miller N, Pintilie M, Fyles T, McCready D, Wong D, Gerster K, Waldron L, Jurisica I, Penn LZ, et al. 2009. Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest 89:597–606.
35. Jazdzewski K, Liyanarachchi S, Swierniak M, Pachucki J, Ringel MD, Jarzab B, de la Chapelle A. 2009. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci USA 106:1502–1505.
36. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. 2008. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 105:7269–7274.
37. Jia H, Yu H, Liu Q. 2016. Single nucleotide polymorphisms of miR-149 gene rs2292832 contributes to the risk of hepatocellular carcinoma, but not overall cancer: a meta-analysis. Minerva Med [Epub ahead of print]
38. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. 2007. The role of site accessibility in microRNA target recognition. Nat Genet 39:1278–1284.
39. Kloosterman WP, Plasterk RH. 2006. The diverse functions of microRNAs in animal development and disease. Dev Cell 11:441–450.
40. Krol J, Loedige I, Filipowicz W. 2010. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11:597–610.
41. Lewis BP, Shih I, Jones-Rhoades MW, Bartel DP, Burge CB. 2003. Prediction of mammalian microRNA targets. Cell 115:787–798.
42. Lewontin RC, Krakauer J. 1973. Distribution of gene frequency as a test of the theory of the selective neutrality of polymorphisms. Genetics 74:175–195.
43. Li H. 2011. Tabix: fast retrieval of sequence features from generic TAB-delimited files. Bioinformatics 27:718–719.
44. Lopez-Valenzuela M, Ramírez O, Rosas A, García-Vargas S, de la Rasilla M, Lalueza-Fox C, Espinosa-Parrilla Y. 2012. An ancestral miR-1304 allele present in neanderthals regulates genes involved in enamel formation and could explain dental differences with modern humans. Mol Biol Evol 29:1797–1806.
45. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, et al. 2005. MicroRNA expression profiles classify human cancers. Nature 435:834–838.
46. Moreno JC, Klootwijk W, van Toor H, Pinto G, D'Alessandro M, Lèger A, Goudie D, Polak M, Grüters A, Visser TJ. 2008. Mutations in the iodotyrosine deiodinase gene and hypothyroidism. N Engl J Med 358:1811–1818.
47. Muiños-Gimeno M, Espinosa-Parrilla Y, Guidi M, Kagerbauer B, Sipilä T, Maron E, Pettai K, Kananen L, Navinés R, Martín-Santos R, Gratacòs M, Metspalu A, et al. 2011. Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways. Biol Psychiatry 69:526–533.
48. Park JY, von Karsa L, Herrero R. 2014. Prevention strategies for gastric cancer: a global perspective. Clin Endosc 47:478–489.
49. Peterson SM, Thompson JA, Ufkin ML, Sathyanarayana P, Liaw L, Congdon CB. 2014. Common features of microRNA target prediction tools. Front Genet 5:1–10.
50. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
51. Prevarskaya N, Ouadid-Ahidouch H, Skryma R, Shuba Y. 2014. Remodelling of Ca2+ transport in cancer: how it contributes to cancer hallmarks? Philos Trans R Soc B Biol Sci 369:20130097–20130097.
52. Qi J, Hou S, Zhang Q, Liao D, Wei L, Fang J, Zhou Y, Kijlstra A, Yang P. 2013. A functional variant of pre-miRNA-196a2 confers risk for Behcet's disease but not for Vogt-Koyanagi-Harada syndrome or AAU in ankylosing spondylitis. Hum Genet 132:1395–1404.
53. Quach H, Barreiro LB, Laval G, Zidane N, Patin E, Kidd KK, Kidd JR, Bouchier C, Veuille M, Antoniewski C, Quintana-Murci L. 2009. Signatures of purifying and local positive selection in human miRNAs. Am J Hum Genet 84:316–327.
54. Rawlings-Goss RA, Campbell MC, Tishkoff SA. 2014. Global population-specific variation in miRNA associated with cancer risk and clinical biomarkers. BMC Med Genomics 7:53.
55. Safford MM, Brown TM, Muntner PM, Durant RW, Glasser S, Halanych JH, Shikany JM, Prineas RJ, Samdarshi T, Bittner VA, Lewis CE, Gamboa C, et al. 2012. Association of race and sex with risk of incident acute coronary heart disease events. JAMA 308:1768–1774.
56. Saunders MA, Liang H, Li W-H. 2007. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA 104:3300–3305.
57. Semb H, Christofori G. 1998. The tumor-suppressor function of E-cadherin. Am J Hum Genet 63:1588–1593.
58. Shalgi R, Lieber D, Oren M, Pilpel Y. 2007. Global and local architecture of the mammalian microRNA–transcription factor regulatory network. PLoS Comput Biol 3:e131.
59. Singleton PA. 2014. Hyaluronan regulation of endothelial barrier function in cancer. Adv Cancer Res 123:191–209.
60. Soldà G, Robusto M, Primignani P, Castorina P, Benzoni E, Cesarani A, Ambrosetti U, Asselta R, Duga S. 2012. A novel mutation within the MIR96 gene causes non-syndromic inherited hearing loss in an Italian family by altering pre-miRNA processing. Hum Mol Genet 21:577–585.
61. Taganov KD, Boldin MP, Chang K-J, Baltimore D. 2006. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103:12481–12486.
62. van Rooij E, Kauppinen S. 2014. Development of microRNA therapeutics is coming of age. EMBO Mol Med 6:851–864.
63. Wan D, Gu W, Xu G, Shen C, Ding D, Shen S, Wang S, Gong X, He S, Zhi Q. 2014. Effects of common polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on susceptibility to colorectal cancer: a systematic review meta-analysis. Clin Transl Oncol 16:792–800.
64. Weir BS, Hill WG. 2002. Estimating F-statistics. Annu Rev Genet 36:721–750.
65. Wu M, Jolicoeur N, Li Z, Zhang L, Fortin Y, L'Abbe D, Yu Z, Shen SH. 2008. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. Carcinogenesis 29:1710–1716.
66. Xiong G, Wang Y, Ding Q, Yang L. 2015. Hsa-mir-1269 genetic variant contributes to hepatocellular carcinoma susceptibility through affecting SOX6. Am J Transl Res 7:2091–2098.
67. Xu B, Feng N-H, Li P-C, Tao J, Wu D, Zhang Z-D, Tong N, Wang J-F, Song N-H, Zhang W, Hua L-X, Wu H-F. 2010. A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo. Prostate 70:467–472.
68. Xu W, Xu J, Liu S, Chen B, Wang X, Li Y, Qian Y, Zhao W, Wu J. 2011. Effects of common polymorphisms rs11614913 in mir-196a2 and rs2910164 in mir-146a on cancer susceptibility: a meta-analysis. PLoS One 6:1–7.
69. Xu Z, Zhang L, Cao H, Bai B. 2014. MiR-146a rs2910164 G/C polymorphism and gastric cancer susceptibility: a meta-analysis. BMC Med Genet 15:1–8.
70. Zeng Y, Cullen BR. 2003. Sequence requirements for micro RNA processing and function in human cells. RNA 9:112–123.
71. Zhou B, Dong L, Jing X, Li J, Yang S, Wang J, Zhao L. 2014. Association between miR-146aG>C and miR-196a2C>T polymorphisms and the risk of hepatocellular carcinoma in a Chinese population. Tumor Biol 35:7775–7780.
72. 1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA. 2012. An integrated map of genetic variation from 1,092 human genomes. Nature 491:56-65